Sun Y - Search Results

1

Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives.

Zhou Y, Xu X, Sun Y, Wang H, Sun H, You Q. Zhou Y, et al. Among authors: sun y, sun h. Bioorg Med Chem Lett. 2013 May 15;23(10):2974-8. doi: 10.1016/j.bmcl.2013.03.037. Epub 2013 Mar 20. Bioorg Med Chem Lett. 2013. PMID: 23566520

2

Synthesis and evaluation of gambogic acid derivatives as antitumor agents. Part III.

Guo XK, Sun HP, Shen S, Sun Y, Xie FL, Tao L, Guo QL, Jiang C, You QD. Guo XK, et al. Among authors: sun hp, sun y. Chem Biodivers. 2013 Jan;10(1):73-85. doi: 10.1002/cbdv.201200126. Chem Biodivers. 2013. PMID: 23341209

3

Targeting Hsp90-Cdc37: A Promising Therapeutic Strategy by Inhibiting Hsp90 Chaperone Function.

Wang L, Li L, Gu K, Xu XL, Sun Y, You QD. Wang L, et al. Among authors: sun y. Curr Drug Targets. 2017;18(13):1572-1585. doi: 10.2174/1389450117666160527125522. Curr Drug Targets. 2017. PMID: 27231111 Review.

4

Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases.

Li Q, Xing S, Chen Y, Liao Q, Li Q, Liu Y, He S, Feng F, Chen Y, Zhang J, Liu W, Guo Q, Sun Y, Sun H. Li Q, et al. Among authors: sun y, sun h. Eur J Med Chem. 2020 Jan 1;185:111862. doi: 10.1016/j.ejmech.2019.111862. Epub 2019 Nov 8. Eur J Med Chem. 2020. PMID: 31735576 Review.

5

Identification of 4-aminoquinoline core for the design of new cholinesterase inhibitors.

Chen Y, Bian Y, Sun Y, Kang C, Yu S, Fu T, Li W, Pei Y, Sun H. Chen Y, et al. Among authors: sun y, sun h. PeerJ. 2016 Jul 7;4:e2140. doi: 10.7717/peerj.2140. eCollection 2016. PeerJ. 2016. PMID: 27441112 Free PMC article.

6

Discovery of novel inhibitors disrupting HIF-1α/von Hippel-Lindau interaction through shape-based screening and cascade docking.

Xue X, Zhao NY, Yu HT, Sun Y, Kang C, Huang QB, Sun HP, Wang XL, Li NG. Xue X, et al. Among authors: sun hp, sun y. PeerJ. 2016 Dec 15;4:e2757. doi: 10.7717/peerj.2757. eCollection 2016. PeerJ. 2016. PMID: 27994971 Free PMC article.

7

Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK).

Xie S, Sun Y, Liu Y, Li X, Li X, Zhong W, Zhan F, Zhu J, Yao H, Yang DH, Chen ZS, Xu J, Xu S. Xie S, et al. Among authors: sun y. J Med Chem. 2021 Jul 8;64(13):9120-9140. doi: 10.1021/acs.jmedchem.1c00270. Epub 2021 Jun 28. J Med Chem. 2021. PMID: 34176264

8

RGD Peptide-Based Target Drug Delivery of Doxorubicin Nanomedicine.

Sun Y, Kang C, Liu F, Zhou Y, Luo L, Qiao H. Sun Y, et al. Drug Dev Res. 2017 Sep;78(6):283-291. doi: 10.1002/ddr.21399. Epub 2017 Aug 16. Drug Dev Res. 2017. PMID: 28815721 Review.

9

Identification by shape-based virtual screening and evaluation of new tyrosinase inhibitors.

Li Q, Yang H, Mo J, Chen Y, Wu Y, Kang C, Sun Y, Sun H. Li Q, et al. Among authors: sun y, sun h. PeerJ. 2018 Jan 26;6:e4206. doi: 10.7717/peerj.4206. eCollection 2018. PeerJ. 2018. PMID: 29383286 Free PMC article.

10

Synthesis, Characterization, and Anticancer Activities Evaluation of Compounds Derived from 3,4-Dihydropyrimidin-2(1H)-one.

Liu Y, Liu J, Zhang R, Guo Y, Wang H, Meng Q, Sun Y, Liu Z. Liu Y, et al. Among authors: sun y. Molecules. 2019 Mar 3;24(5):891. doi: 10.3390/molecules24050891. Molecules. 2019. PMID: 30832453 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65,287 results

Search Page

Filters